Recombinant factor VIIa in massive obstetric haemorrhage.
Bhuskute
N
N
Kritzinger
S
S
Dakin
M
M
D000328:Adult; D000768:Anesthesia, General / Q000379:methods; D000775:Anesthesia, Spinal / Q000379:methods; D016063:Blood Loss, Surgical; D001792:Blood Platelets; D003029:Coagulants / Q000627:therapeutic use*; D000077324:Crystalloid Solutions; D004912:Erythrocytes; D005169:Factor VIII / Q000008:administration & dosage; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D005340:Fibrinogen / Q000008:administration & dosage; D006801:Humans; D007044:Hysterectomy; D007431:Intraoperative Complications; D007552:Isotonic Solutions / Q000008:administration & dosage; D010921:Placenta Accreta / Q000601:surgery; D010923:Placenta Previa / Q000601:surgery*; D010949:Plasma; D006473:Postpartum Hemorrhage / Q000188:drug therapy* / Q000601:surgery; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000601:surgery; D011994:Recombinant Proteins / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome
D003029:Coagulants; D000077324:Crystalloid Solutions; D007552:Isotonic Solutions; D011994:Recombinant Proteins; C026912:cryoprecipitate coagulum; D005169:Factor VIII; D005340:Fibrinogen; C103587:recombinant FVIIa; D015942:Factor VIIa